Venkata K. Pokuri

A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer

Renuka Iyer, Venkata K. Pokuri, Adrienne Groman et al. · American Journal of Clinical Oncology · 2016 · 82 citations

Medicine, Oncology, Pharmacology +17

Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study

S. Samuel, Sarbajit Mukherjee, Nischala Ammannagari et al. · PLoS ONE · 2018 · 63 citations · Full text

Medicine, Oncology, Pathology +17

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

Venkata K. Pokuri, Johar Syed, Zhengyu Yang et al. · Clinical Genitourinary Cancer · 2015 · 62 citations

Medicine, Oncology, Urology +12

Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience

Smit Singla, Charles LeVea, Venkata K. Pokuri et al. · Journal of Gastrointestinal Oncology · 2016 · 30 citations · Full text

Medicine, Oncology, Surgery +17

Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC)

Venkata K. Pokuri, Garin Tomaszewski, Sihem Ait‐Oudhia et al. · American Journal of Clinical Oncology · 2016 · 21 citations

Medicine, Oncology, Pharmacology +17